Table 3.
Correlation analysis of HCBs grade with variables in MSA patients.
Variables | Overall | (n = 81) | MSA-C | (n = 50) | MSA-P | (n = 31) |
---|---|---|---|---|---|---|
r | p† | r | p† | r | p† | |
Autonomic failure | ||||||
Orthostatic hypotension | −0.085 | 0.453 | −0.061 | 0.675 | −0.179 | 0.335 |
Urinary incontinence | 0.119 | 0.288 | 0.139 | 0.337 | 0.089 | 0.636 |
Incomplete bladder empty | 0.043 | 0.706 | −0.026 | 0.859 | 0.195 | 0.294 |
Constipation | 0.180 | 0.108 | 0.177 | 0.220 | 0.186 | 0.316 |
Cerebellar dysfunction | ||||||
Gait ataxia | 0.177 | 0.114 | 0.021 | 0.885 | 0.314 | 0.086 |
Limb ataxia | 0.308 | 0.005 | 0.183 | 0.203 | 0.442 | 0.013 |
Cerebellar dysarthria | 0.261 | 0.019 | 0.319 | 0.024 | 0.091 | 0.627 |
Nystagmus | −0.135 | 0.230 | −0.194 | 0.178 | … | … |
Parkinsonism | ||||||
Bradykinesia | −0.041 | 0.719 | 0.084 | 0.563 | −0.219 | 0.236 |
Rigidity | −0.116 | 0.304 | −0.043 | 0.766 | −0.183 | 0.325 |
Postural instability | −0.161 | 0.152 | −0.163 | 0.258 | −0.123 | 0.509 |
Resting tremor | −0.059 | 0.604 | 0.110 | 0.447 | −0.277 | 0.132 |
Corticospinal dysfunction | ||||||
Babinski sign | 0.174 | 0.120 | 0.196 | 0.173 | 0.166 | 0.373 |
Atypical symptoms | ||||||
Dementia | −0.081 | 0.471 | −0.110 | 0.446 | −0.022 | 0.906 |
Neurological Scores | ||||||
SARA | 0.594 | <0.001 | 0.788 | <0.001 | 0.326 | 0.073 |
UMSARS-IV | 0.560 | <0.001 | 0.794 | <0.001 | 0.154 | 0.408 |
Imaging features | ||||||
Atrophy of pons | −0.311 | 0.005 | −0.271 | 0.057 | −0.357 | 0.048 |
Atrophy of MCP | −0.411 | <0.001 | −0.383 | 0.006 | −0.434 | 0.015 |
Disease duration | 0.179 | 0.093 | 0.109 | 0.520 | 0.376 | 0.037 |
Age on symptom onset | −0.061 | 0.587 | −0.582 | 0.573 | −0.132 | 0.479 |
†Based on Spearman test, significance level of 0.05 (two-tailed).
UMSARS Unified Multiple System Atrophy Rating Scale, MSA-C multiple system atrophy (cerebellar subtype), MSA-P multiple system atrophy (parkinsonism subtype), MCP middle cerebellar peduncles.